Assenagon Asset Management Portfolio holdings
AUM
$63B
This Quarter Return
+12.51%
1 Year Return
+16.23%
3 Year Return
+96.75%
5 Year Return
+146.12%
10 Year Return
–
AUM
$63B
AUM Growth
+$63B
(+12%)
Cap. Flow
+$379M
Cap. Flow
% of AUM
0.6%
Top 10 Holdings %
Top 10 Hldgs %
32.58%
Holding
1,235
New
110
Increased
453
Reduced
480
Closed
111
Top Buys
| 1 |
Adobe
ADBE
|
$908M |
| 2 |
Broadcom
AVGO
|
$845M |
| 3 |
AbbVie
ABBV
|
$681M |
| 4 |
Apple
AAPL
|
$639M |
| 5 |
Eli Lilly
LLY
|
$596M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$2.95B |
| 2 |
Tesla
TSLA
|
$1.58B |
| 3 |
Microsoft
MSFT
|
$1.02B |
| 4 |
Meta Platforms (Facebook)
META
|
$919M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$896M |
Sector Composition
| 1 | Technology | 36.29% |
| 2 | Consumer Discretionary | 15% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 7.95% |
| 5 | Financials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Western New England Bancorp
WNEB
$257M
| $161K | ﹤0.01% | +17,394 | New | +$161K |
|
1102
Ovid Therapeutics
OVID
$91M
| $144K | ﹤0.01% | 435,620 -125,210 | -22% | -$41.3K |
|
1103
TripAdvisor
TRIP
$2.02B
| $144K | ﹤0.01% | 11,007 -595,000 | -98% | -$7.76M |
|
1104
Titan International
TWI
$564M
| $140K | ﹤0.01% | 13,622 | – | – |
|
|
NIU
1105
Niu Technologies
NIU
$341M
| $137K | ﹤0.01% | 40,865 -100,871 | -71% | -$339K |
|
1106
Commercial Vehicle Group
CVGI
$65.1M
| $137K | ﹤0.01% | 82,569 +45,944 | +125% | +$76.3K |
|
1107
Digital Turbine
APPS
$455M
| $135K | ﹤0.01% | 22,933 -7,383 | -24% | -$43.6K |
|
1108
Arbutus Biopharma
ABUS
$711M
| $122K | ﹤0.01% | +39,610 | New | +$122K |
|
1109
Alphatec Holdings
ATEC
$2.35B
| $116K | ﹤0.01% | 10,447 | – | – |
|
1110
Forrester Research
FORR
$186M
| $109K | ﹤0.01% | 11,019 | – | – |
|
1111
DHI Group
DHX
$132M
| $108K | ﹤0.01% | 36,475 | – | – |
|
1112
Clearside Biomedical
CLSD
$28.9M
| $106K | ﹤0.01% | 131,913 | – | – |
|
1113
Design Therapeutics
DSGN
$315M
| $105K | ﹤0.01% | 31,125 -5,792 | -16% | -$19.5K |
|
1114
Denny's
DENN
$235M
| $103K | ﹤0.01% | 25,147 | – | – |
|
1115
Iovance Biotherapeutics
IOVA
$807M
| $80.6K | ﹤0.01% | 46,842 | – | – |
|
1116
Cullinan Oncology
CGEM
$445M
| $75.8K | ﹤0.01% | 10,062 | – | – |
|
1117
GoPro
GPRO
$247M
| $71.3K | ﹤0.01% | 94,166 -203,280 | -68% | -$154K |
|
1118
Altice USA
ATUS
$1.1B
| $59.5K | ﹤0.01% | 27,791 | – | – |
|
1119
Neuronetics
STIM
$220M
| $48K | ﹤0.01% | 13,761 -83,895 | -86% | -$293K |
|
1120
AXT Inc
AXTI
$134M
| $42.7K | ﹤0.01% | 20,412 | – | – |
|
1121
Nuvation Bio
NUVB
$1.02B
| $35.5K | ﹤0.01% | 18,209 -5,806 | -24% | -$11.3K |
|
1122
Vera Bradley
VRA
$57.8M
| $32.8K | ﹤0.01% | 14,859 -4,986 | -25% | -$11K |
|
1123
Noodles & Co
NDLS
$33.1M
| $17.9K | ﹤0.01% | 25,122 | – | – |
|
1124
Harvard Bioscience
HBIO
$22M
| $16.3K | ﹤0.01% | 36,801 -17,625 | -32% | -$7.82K |
|
1125
Applied Optoelectronics
AAOI
$1.51B
| – | – | -976,520 | Closed | -$15M |
|